2m 2m 2m 2m 2m 2m 2m
REPLIMUNE GRP (REPL)
NASDAQ
$11.92+$0.19 (+1.66%)
Price as of Oct 22, 2026 7:35 PM EDT- $1.1BMarket Cap
- 41.20%1-Year Change
- BiotechnologyIndustry
REPLIMUNE GRP (REPL)
$11.92+$0.19 (+1.66%)
REPL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $11.72 | ||
Change | +$0.30 (+2.63%) | ||
Open | $11.37 | ||
High | $12.04 | ||
Low | $11.31 | ||
Previous Close | $11.42 | ||
Volume | 2,202,154 | ||
30-Day Average Volume | 1,989,993 | ||
1-Week Change | 2.90% | ||
1-Month Change | -8.94% | ||
1-Year Change | 41.20% | ||
3-Year Change | -21.02% | ||
5-Year Change | -59.50% | ||
Fundamentals | |||
Shares Outstanding | 94.2M | ||
Total Assets | $252.4M | ||
Market Cap | $1.1B | ||
Enterprise Value | $1.0B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$69.8M | ||
Free Cash Flow | -$75.7M | ||
EBIT | -$67.2M | ||
EBITDA | -$66.2M | ||
Net Working Capital | $162.4M | ||
EPS | -$0.72 | ||
Enterprise Value/EBITDA | -15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -16 | ||
PEG | -3 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 15 : 1 | ||
Last Split Date | 12/01/2010 | ||
Earnings & Revenue